Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
ClinicalTrials.gov study NCT04551430. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Antibody Improve Mixed Chimerism
ClinicalTrials.gov study NCT04944511. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT06405425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
ClinicalTrials.gov study NCT03607890. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT05259397. IPD Sharing: NO. Countries: 2. Publications: 0.
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06492759. IPD Sharing: Not stated. Countries: 1. Publications: 0.
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
ClinicalTrials.gov study NCT06099821. IPD Sharing: NO. Countries: 1. Publications: 0.
SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC
ClinicalTrials.gov study NCT05747716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)
ClinicalTrials.gov study NCT01918176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)
ClinicalTrials.gov study NCT04922190. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and PK-PD Study of Oral L-CIT in Preterm Infants with BPD±PH and NEC
ClinicalTrials.gov study NCT05636397. IPD Sharing: NO. Countries: 1. Publications: 0.
Bayston Multicenter Antimicrobial PD Catheter Safety Study
ClinicalTrials.gov study NCT02274896. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants
ClinicalTrials.gov study NCT05863442. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
ClinicalTrials.gov study NCT06666283. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
ClinicalTrials.gov study NCT05681039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
ClinicalTrials.gov study NCT07376512. IPD Sharing: NO. Countries: 1. Publications: 0.
QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
ClinicalTrials.gov study NCT04050709. IPD Sharing: NO. Countries: 1. Publications: 0.
Longitudinal Outcomes of DBS in PD
ClinicalTrials.gov study NCT03582163. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients
ClinicalTrials.gov study NCT00332917. IPD Sharing: Not stated. Countries: 21. Publications: 0.
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects
ClinicalTrials.gov study NCT05095168. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.